Form 4: Merit Medical Systems Executive Exercises Stock Options
SEC Form 4 Filing
Neil Peterson, Chief Operating Officer of Merit Medical Systems, exercised stock options on March 6, 2024, acquiring 7,500 shares of common stock.
Summary
- On March 6, 2024, Neil Peterson, the Chief Operating Officer of Merit Medical Systems, exercised stock options, acquiring 7,500 shares of common stock at a price of $44.80 per share.
- Following the transaction, Peterson directly owns 14,819 shares of Merit Medical Systems common stock.
- The exercised options were non-qualified stock options that became exercisable in installments beginning on March 2, 2019.
- Peterson also holds other non-qualified stock options to purchase additional shares at various exercise prices and expiration dates.
Sentiment
Score: 6
Explanation: The sentiment is neutral. It's a routine filing related to stock option exercises. While it indicates the executive's confidence, it doesn't necessarily signal a major positive or negative event.
Positives
- The exercise of stock options by a company executive can be seen as a positive sign, indicating confidence in the company's future performance.
Industry Context
Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. This filing indicates that the COO is exercising previously granted stock options, which is a common practice.
Comparison to Industry Standards
- Executive compensation packages often include stock options to align management's interests with those of shareholders.
- The vesting schedules and exercise prices of these options are typical for the industry.
- Comparing the total number of options held and exercised by Neil Peterson to those of executives at comparable medical device companies like Boston Scientific or Medtronic would provide further context.
Stakeholder Impact
- The transaction has a minor impact on shareholders as it slightly increases the number of outstanding shares.
Key Dates
| Date | Description |
|---|---|
| 03/02/2019 | Date when the first tranche of the exercised stock options became exercisable. |
| 04/25/2020 | Date when the first tranche of the non-qualified stock options at $54.40 became exercisable. |
| 08/19/2022 | Date when the first tranche of the non-qualified stock options at $68.33 became exercisable. |
| 02/28/2024 | Date when the first tranche of the non-qualified stock options at $70.58 became exercisable. |
| 03/06/2024 | Date of the stock option exercise transaction. |
| 03/08/2024 | Date of the Form 4 filing. |
| 03/02/2025 | Expiration date of the exercised stock options. |
| 04/25/2026 | Expiration date of the non-qualified stock options at $54.40. |
| 08/19/2028 | Expiration date of the non-qualified stock options at $68.33. |
| 02/28/2030 | Expiration date of the non-qualified stock options at $70.58. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.